Related Experiment Video
Updated: Dec 24, 2025

07:41
Author Spotlight: Automated Bioprinting for High-Throughput Vascular Model Fabrication
Published on: August 16, 2024
1.5K
High throughput direct 3D bioprinting in multiwell plates
Henry H Hwang1,2, Shangting You1,2, Xuanyi Ma3
1Department of NanoEngineering, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093, United States of America.
Biofabrication
|April 17, 2020
Summary
High throughput 3D bioprinting enables rapid, in situ fabrication of complex tissue scaffolds in multiwell plates. This advancement accelerates in vitro 3D tissue model generation for drug screening and disease modeling.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Biotechnology
Background:
- High throughput production of 3D tissue scaffolds in multiwell plates is critical for biological and medical applications.
- Existing 3D bioprinting methods face limitations in speed and scalability for large-scale applications.
Purpose of the Study:
- To present an integrated 3D bioprinting platform for high throughput, in situ fabrication of complex 3D biomedical samples.
- To demonstrate the capability of the platform for creating biomimetic tissue scaffolds with tunable properties and reproducibility.
- To validate the platform's utility in drug response assays and dual-cell type tissue fabrication.
Main Methods:
- Development of a high throughput 3D bioprinter (HT-3DP) utilizing microscale continuous optical printing.
- Fabrication of 3D tissue scaffolds with controlled spatial geometries and mechanical properties in multiwell plate formats.
- In situ drug response assay using hepatocellular carcinoma 3D tissue scaffolds and doxorubicin.
- Printing of dual-cell type constructs involving hepatocellular carcinoma and human umbilical vein endothelial cells.
Main Results:
- Successful high throughput, in situ fabrication of complex 3D biomedical samples in multiwell plates.
- Demonstration of constructs with biomimetic significance, tunable mechanical properties, and reproducibility.
- Functional drug response assay performed on 3D bioprinted hepatocellular carcinoma tissue scaffolds.
- Successful fabrication of dual-cell type 3D tissue models.
Conclusions:
- The developed HT-3DP platform significantly advances 3D bioprinting capabilities for high throughput applications.
- Enables rapid generation of in vitro 3D tissue models within conventional multiwell plates.
- Facilitates high throughput preclinical drug screening and disease modeling.

